Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ANTARES PHARMA INC | 8,723,052 | reported | 26 Jun 2015 | tx 21−756,852 |
| ALIMERA SCIENCES INC | 4,760,408 | reported | 08 Dec 2015 | tx 12+662,289 |
| Axogen, Inc. | 3,381,439 | reported | 18 Sept 2015 | tx 1−345,000 |
| Vanda Pharmaceuticals Inc. | 2,149,462 | reported | 11 Dec 2015 | tx 18+1,627,346 |
| NITROMED INC | 1,904,521 | reported | 21 Jul 2008 | tx 16+333,069 |
| NeuroMetrix, Inc. | 1,574,478 | reported | 26 Oct 2010 | tx 6−119,200 |
| XCYTE THERAPIES INC | 1,177,454 | reported | 14 Nov 2008 | tx 6−298,230 |
| Hana Biosciences Inc | 946,926 | reported | 03 May 2012 | tx 40+64,582−391,052 |
| eHealth, Inc. | 923,448 | reported | 14 Jun 2016 | tx 1−43,300 |
| NxStage Medical, Inc. | 907,746 | reported | 16 Sept 2009 | tx 13−226,638 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Feb 2019 | SALE | XERIS PHARMACEUTICALS INC | 5,890 | 15.11 USD | |
| 11 Feb 2019 | SALE | XERIS PHARMACEUTICALS INC | 1,351 | 15.00 USD | |
| 28 Dec 2018 | OTHER | Aclaris Therapeutics, Inc. | 1 | — | deriv |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 99,830 | — | |
| 25 Jul 2016 | PURCHASE | Audentes Therapeutics, Inc. | 146,596 | 15.00 USD | |
| 25 Jul 2016 | PURCHASE | Audentes Therapeutics, Inc. | 253,404 | 15.00 USD | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 99,830 | — | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 535,996 | — | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 267,998 | — | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 99,830 | — | deriv |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 99,830 | — | deriv |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 535,996 | — | deriv |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 267,998 | — | deriv |
| 14 Jun 2016 | SALE | eHealth, Inc. | 43,300 | 13.88 USD | |
| 11 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 128,374 | 8.61 USD | |
| 11 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 93,634 | 8.61 USD | |
| 09 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 229,833 | 8.21 USD | |
| 09 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 292,515 | 8.21 USD | |
| 09 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 213,358 | 8.21 USD | |
| 09 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 15,775 | 9.00 USD | |
| 09 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 11,506 | 9.00 USD | |
| 10 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 40,997 | 8.59 USD | |
| 10 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 32,211 | 8.59 USD | |
| 10 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 29,902 | 8.59 USD | |
| 11 Dec 2015 | PURCHASE | Vanda Pharmaceuticals Inc. | 100,864 | 8.61 USD |
4 purchases reported after at least 12 months of silence — most recent on 19 Oct 2015.